Rafferty Asset Management Portfolio holdings
AUM
$30.3B
1-Year Return
18.89%
This Quarter Return
-4.21%
1 Year Return
+18.89%
3 Year Return
+101.02%
5 Year Return
+164.75%
10 Year Return
+314.44%
AUM
$16.9B
AUM Growth
-$2.13B
(-11%)
Cap. Flow
-$1.08B
Cap. Flow
% of AUM
-6.37%
Top 10 Holdings %
Top 10 Hldgs %
39.23%
Holding
1,372
New
74
Increased
459
Reduced
680
Closed
155
Top Buys
| 1 |
Advanced Micro Devices
AMD
|
+$126M |
| 2 |
NVIDIA
NVDA
|
+$75.8M |
| 3 |
Synaptics
SYNA
|
+$33.9M |
| 4 |
Microchip Technology
MCHP
|
+$29.7M |
| 5 |
ON Semiconductor
ON
|
+$23.8M |
Top Sells
| 1 |
iShares Russell 2000 ETF
IWM
|
+$185M |
| 2 |
XLNX
Xilinx Inc
XLNX
|
+$169M |
| 3 |
iShares China Large-Cap ETF
FXI
|
+$154M |
| 4 |
Apple
AAPL
|
+$136M |
| 5 |
Berkshire Hathaway Class B
BRK.B
|
+$120M |
Sector Composition
| 1 | Technology | 36.16% |
| 2 | Financials | 15.02% |
| 3 | Energy | 6.15% |
| 4 | Healthcare | 5.33% |
| 5 | Consumer Discretionary | 2.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
376
Bristol-Myers Squibb
BMY
$94B
| $5.33M | 0.03% |
72,968
-17,007
| -19% | -$1.24M |
|
377
Celldex Therapeutics
CLDX
$1.62B
| $5.32M | 0.03% |
156,252
+12,137
| +8% | +$413K |
|
|
UMPQ
378
DELISTED
Umpqua Holdings Corp
UMPQ
| $5.31M | 0.03% |
281,595
-9,564
| -3% | -$180K |
|
379
Kymera Therapeutics
KYMR
$3.36B
| $5.25M | 0.03% |
124,128
+28,352
| +30% | +$1.2M |
|
380
Prothena Corp
PRTA
$442M
| $5.25M | 0.03% |
143,547
+22,879
| +19% | +$837K |
|
381
Cytokinetics
CYTK
$6.12B
| $5.25M | 0.03% |
142,602
-3,466
| -2% | -$128K |
|
382
Assurant
AIZ
$10.7B
| $5.2M | 0.03% |
28,596
-1,380
| -5% | -$251K |
|
|
TPTX
383
DELISTED
Turning Point Therapeutics, Inc. Common Stock
TPTX
| $5.19M | 0.03% |
193,126
+58,489
| +43% | +$1.57M |
|
384
Beam Therapeutics
BEAM
$2.08B
| $5.18M | 0.03% |
90,383
+16,604
| +23% | +$951K |
|
385
Agios Pharmaceuticals
AGIO
$2.14B
| $5.18M | 0.03% |
177,859
-413
| -0.2% | -$12K |
|
386
Allogene Therapeutics
ALLO
$251M
| $5.17M | 0.03% |
567,918
+272,539
| +92% | +$2.48M |
|
|
SWTX
387
DELISTED
SpringWorks Therapeutics
SWTX
| $5.13M | 0.03% |
90,829
+15,538
| +21% | +$877K |
|
388
Arcus Biosciences
RCUS
$1.23B
| $5.1M | 0.03% |
161,554
+35,236
| +28% | +$1.11M |
|
389
Relay Therapeutics
RLAY
$688M
| $5.1M | 0.03% |
170,274
-19,728
| -10% | -$590K |
|
390
Globe Life
GL
$11.5B
| $5.07M | 0.03% |
50,393
-2,442
| -5% | -$246K |
|
391
Northern Oil and Gas
NOG
$2.48B
| $5.06M | 0.03% |
179,478
-26,311
| -13% | -$742K |
|
|
VXRT
392
DELISTED
Vaxart
VXRT
| $5.02M | 0.03% |
996,455
+148,681
| +18% | +$749K |
|
393
Annaly Capital Management
NLY
$14.1B
| $5.01M | 0.03% |
177,719
-6,626
| -4% | -$187K |
|
394
Axon Enterprise
AXON
$59.4B
| $4.98M | 0.03% |
36,188
-5,756
| -14% | -$793K |
|
395
TopBuild
BLD
$11.7B
| $4.98M | 0.03% |
27,433
-6,675
| -20% | -$1.21M |
|
396
American Financial Group
AFG
$11.7B
| $4.97M | 0.03% |
34,118
-1,653
| -5% | -$241K |
|
|
BLDP
397
Ballard Power Systems
BLDP
$622M
| $4.94M | 0.03% |
424,263
+73,785
| +21% | +$859K |
|
398
Protagonist Therapeutics
PTGX
$3.66B
| $4.93M | 0.03% |
208,094
+42,322
| +26% | +$1M |
|
399
Clean Energy Fuels
CLNE
$526M
| $4.8M | 0.03% |
604,449
-389,533
| -39% | -$3.09M |
|
400
Expedia Group
EXPE
$27.5B
| $4.78M | 0.03% |
24,427
+331
| +1% | +$64.8K |
|